Scanogen Receives FDA Breakthrough Device Designation for Rapid Bloodstream Infection Assay

[#item_full_content]BALTIMORE–(BUSINESS WIRE)– #Healthcare–Scanogen Inc. received FDA Breakthrough Device status for its rapid assay that identifies bloodstream infection pathogens in just two hours.